---
figid: PMC4522583__gr2
figtitle: Schematic overview of a potential I1 and adenosine receptors crosstalk
organisms:
- Mus musculus
- Rattus norvegicus
- Cricetulus griseus
- Homo sapiens
- Bos taurus
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4522583
filename: gr2.jpg
figlink: /pmc/articles/PMC4522583/figure/f0010/
number: F2
caption: Schematic overview of a potential I1 and adenosine receptors crosstalk. Reference
  is made to the signaling cascades of the adenosine A1 and A2A receptor subtypes.
  Adenosine A2A receptor activation with the nonselective agonist adenosine or the
  more selective agonist CGS21680 leads to enhanced expression of pERK1/2 via a cAMP-dependent
  or independent mechanism. I1 activation with its respective agonist, clonidine or
  rilmenidine, enhances expression of pERK1/2 via a PC-PLC pathway. pERK1/2 activates
  neuronal nitric oxide synthase (NOS) which causes increased production of NO and
  decreased sympathetic neuronal activity.
papertitle: 'Brain stem adenosine receptors modulate centrally mediated hypotensive
  responses in conscious rats: A review.'
reftext: Noha N. Nassar, et al. J Adv Res. 2015 May;6(3):331-340.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9105536
figid_alias: PMC4522583__F2
figtype: Figure
redirect_from: /figures/PMC4522583__F2
ndex: 9fac794a-df11-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4522583__gr2.html
  '@type': Dataset
  description: Schematic overview of a potential I1 and adenosine receptors crosstalk.
    Reference is made to the signaling cascades of the adenosine A1 and A2A receptor
    subtypes. Adenosine A2A receptor activation with the nonselective agonist adenosine
    or the more selective agonist CGS21680 leads to enhanced expression of pERK1/2
    via a cAMP-dependent or independent mechanism. I1 activation with its respective
    agonist, clonidine or rilmenidine, enhances expression of pERK1/2 via a PC-PLC
    pathway. pERK1/2 activates neuronal nitric oxide synthase (NOS) which causes increased
    production of NO and decreased sympathetic neuronal activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - XYLT2
  - SOS1
  - SOS2
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - ATP8A2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - CALM2
  - NOS1
  - NOS2
  - NOS3
  - Sos
  - norpA
  - sl
  - Plc21C
  - ac
  - ATPsynbeta
  - Atpalpha
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Nos
  - nos
  - adenosine
  - Clonidine
  - glutamate
---
